October 25, 2007
In what qui tam lawyers say is an unusual development, the whistleblower who exposed a fraudulent drug marketing scheme at Cell Therapeutics may receive nothing as his relator’s share.
Justice Department officials content that James Marchese was a planner or initiator of the very scheme he exposed. Although according to the October 25, 2007 article in the New York Times, the Justice Department has not indicted him for his alleged actions, they argue that he is not entitled to any relator’s share.
We had reported on the Cell Therapeutics settlement on April 19, 2007.